Last update 20 Mar 2025

Technetium Tc99M Albumin Aggregated

Overview

Basic Info

Drug Type
Diagnostic radiopharmaceuticals, Protein drugs
Synonyms
kit for the preparation of technetium Tc-99m albumin aggregated (Cis Bio International), Pulmotech MAA
Target-
Action-
Mechanism-
Therapeutic Areas
Respiratory Diseases
Active Indication
Lung Diseases
Inactive Indication-
Originator Organization
CIS BIO INTL
Active Organization
CIS BIO INTLJubilant DraxImage, Inc.Jubilant DraxImage, Inc.Startup
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (30 Dec 1987),
Lung Diseases
Regulation-
Login to view timeline

Structure/Sequence

Related

100 Clinical Results associated with Technetium Tc99M Albumin Aggregated
Login to view more data
100 Translational Medicine associated with Technetium Tc99M Albumin Aggregated
Login to view more data
100 Patents (Medical) associated with Technetium Tc99M Albumin Aggregated
Login to view more data
100 Deals associated with Technetium Tc99M Albumin Aggregated
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Lung Diseases
United States
Jubilant DraxImage, Inc.Jubilant DraxImage, Inc.Startup
30 Dec 1987
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free